References
- Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th ed. New York: Churchill Livingstone, 2000: 271–321.
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603–62
- Vakulenko SB, Mobashery S. Versatility of aminoglyco-sides and prospects for their future. Clin Microbiol Rev 2003; 16: 430–50.
- Hull SI, Wallace RJJr, Bobey DG, et al. Presence of aminoglycoside acetyltransferase and plasmids in Mycobacterium fortuitum. Am Rev Respir Dis 1984; 129: 614–8.
- Udou T, Mizuguchi Y, Wallace RJJr. Patterns and distri-bution of aminoglycoside- acetylating enzymes in rapidly grow-ing mycobacteria. Am Rev Respir Dis 1987; 136: 338–43.
- Ainsa JA, Perez E, Pelicic V, Berthet FX, Gicquel B, Martin C. Aminoglycoside 2'-N-acetyltransf erase genes are universally present in mycobacteria: characterization of the aac(2')-k gene from Mycobacterium tuberculosis and the aac(2')-Id gene from Mycobacterium smegmatis. Mol Microbiol 1997; 24: 431?41.
- Hegde SS, Javid-Majd F, Blanchard JS. Overexpression and mechanistic analysis of chromosomally encoded aminogly-coside 2'-N-acetyltransferase (AAC(2')-Ic) from Mycobacterium tuberculosis. J Biol Chem 2001; 276: 45876–81.
- Matsuhashi Y, Yamamoto H. Enzymatic mechanism of resistance to aminoglycoside antibiotics in methicillin-resistant Staphylococcus aureus. Jap J Antibiot 1988; 41: 523–9. (in Japanese with English abstract)
- Udou T. Extracellular hemolytic activity in rapidly grow-ing mycobacteria. Can J Microbiol 1994; 40: 318–21.
- Goto Y, Taniguchi H, Udou T, Mizuguchi Y, Tokunaga T. Development of a new host-vector system in mycobacteria. FEMS Microbiol Lett 1991; 83: 277–82.
- Udou T. Dissemination of nosocomial multiple-amino-glycoside-resistant Staphylococcus aureus caused by horizon-tal transfer of the resistant determinant (aacA/aphD) and clon-al spread of resistant strains. Am J Infect Control 2004; 32: 215–9.
- Kusunoki S, Ezaki T, Tamesada M, et al. Application of colorimetric microdilution plate hybridization for rapid genetic identification of 22 Mycobacterium species. J Clin Microbiol 1991; 29: 1596–603.
- National Committee for Clinical Laboratory Standards (NCCLS). Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; Approved standard. Wayne, Pennsylvania: NCCLS, 2003; Document M24-A
- Wallace RJJr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5: 657–79.
- American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1–S25.
- Swenson JM, Wallace RJJr, Silcox VA, Thornsberry C.Antimicrobial susceptibility testing of 5 subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28: 807–11.
- Yamasaku F, Suzuki Y, Shinkai S, Shomura T, Komiya I. Pharmacokinetics of HBK in healthy adult volunteers. Chemotherapy 1986; 34: 117–28. (in Japanese with English abstract)
- American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990; 142: 940–53.
- Rastogi N, Frehel C, Ryter A, Ohayon H, Lesourd M, David HL. Multiple drug resistance in Mycobacterium auium: is the wall architecture responsible for the exclusion of antimi-crobial agents? Antimicrob Agents Chemother 1981; 20: 666-77.
- Mizuguchi Y, Udou T, Yamada T. Mechanism of antibi-otic resistance in Mycobacterium intracellulare. Micobiol Immunol 1983; 27: 425–31.
- Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanisms of multiple drug resis-tance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995; 171: 954–60.
- Peloquin CA, Berning SE, Nitta AT, et al. Aminoglycoside toxicity; Daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis 2004; 38: 1538–44.
- Chan ED, Laurel V, Strand MJ, Chan JF, Huynh MN, Goble M, Iseman MD. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169: 1103-19.